Investors

Investor Contact

	2012 Annual Report (HTML)
	2012 10-K

914-847-5126
invest@regeneron.com

Questions for the Investor Relations Department can be submitted through the form below. * Required fields

Name *
Email *
Topic *
Subject *
Comments *
Type in number *
	This helps Regeneron Pharmaceuticals, Inc. prevent automated submissions.